Abstract
Risks, benefits, alternatives, and appropriateness of psychotropic medications, including risks of no treatment, are discussed for antidepressants, mood-stabilizing medications, anxiolytic/sedative hypnotic medications, stimulants, and medication-assisted treatment of substance use disorders. Early screening, diagnosis, and intervention prior to and/or during pregnancy often reduce morbidity and mortality of mental health disorders for mothers and infants.
Keywords:
Perinatal addiction; Perinatal reproductive psychiatry; Pregnancy; Psychopharmacology; Women’s mental health.
Copyright © 2019 Elsevier Inc. All rights reserved.
MeSH terms
-
Antidepressive Agents / therapeutic use
-
Antimanic Agents / therapeutic use
-
Antipsychotic Agents / therapeutic use
-
Bipolar Disorder / drug therapy
-
Depressive Disorder / drug therapy
-
Female
-
Fetal Alcohol Spectrum Disorders / epidemiology
-
Humans
-
Maternal-Fetal Exchange
-
Mental Disorders / drug therapy*
-
Opioid-Related Disorders
-
Persistent Fetal Circulation Syndrome / epidemiology
-
Postpartum Hemorrhage / epidemiology
-
Pregnancy
-
Pregnancy Complications / drug therapy*
-
Prenatal Exposure Delayed Effects / epidemiology*
-
Psychotic Disorders / drug therapy
-
Psychotropic Drugs / therapeutic use*
-
Severity of Illness Index
-
Substance Withdrawal Syndrome
-
Substance-Related Disorders / therapy
Substances
-
Antidepressive Agents
-
Antimanic Agents
-
Antipsychotic Agents
-
Psychotropic Drugs